N/A
N=168
Magnetic Resonance Imaging Study of Acute Pancreatitis
Acute Pancreatitis
Bottom Line
View on ClinicalTrials.gov: NCT01911689 ↗Enrolled (actual)
168
Serious AEs
0.0%
Results posted
Aug 2015
Primary outcome: Primary: The T2* Values in the Diagnosis of AP — 25.86; 21.06 ms — p=<0.01
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Primary completion
- Mar 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The T2* Values in the Diagnosis of AP |
25.86; 21.06 | <0.01 sig |
| SECONDARY The Difference of T2* Value Between the Edematous AP and Necrotizing AP |
25.28; 28.10 | 0.05 |
| SECONDARY The T2* Value in Different Severity of AP According to MRSI |
24.08; 26.49; 29.99 | <0.01 sig |
| SECONDARY The Relationship Between the T2* Value and the Severity of AP According to Apache II |
25.73; 26.25 | 0.629 |
Summary
To quantitatively analyze the T2* values of the head, body, and tail of normal pancreas, and observe the value of GRE T2*-weighted MRI in the diagnosis of acute pancreatitis and the relationship between the T2* value and the severity of AP.
Eligibility Criteria
Inclusion Criteria
- acute onset of abdominal pain;
- pancreatitis at first onset;
- three-fold elevated amylase or lipase, excluding other causes of elevated enzymes; and
- abdominal MR examination.
Exclusion Criteria
- inability to cooperate when MR imaging was performed;
- a history of chronic pancreatitis;
- AP due to pancreatic carcinoma;
- hypoproteinemia;
- with hypoproteinemia and other peritoneal/ retroperitoneal infection diseases ;
- with iron deposition disorder (e.g. diabetes or blood system diseases).
Data sourced from ClinicalTrials.gov (NCT01911689). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.